9
report
Employer Investments in Digital, Whole-Person Health for Substance Use Disorders
Employers seek to support their employees while normalizing a whole-person approach to substance us
e disorders (SUD). The response to addiction and the opioid crisis requires a whole-of-society approach, including employers of all sizes.
+ Read More
report
Toward a National Action Plan for Achieving Diversity in Clinical Trials
Participation in clinical research among racial and ethnic minorities remains low, even though such
groups now represent nearly 40 percent of the US population.
+ Read More
article
Comments on Collection of Race and Ethnicity Data in Clinical Trials and Clinical Studies for FDA-Regulated Medical Products, Federal Register Docket FDA-2016-D-3561
Lauren K. Roth
Associate Commissioner for Policy
Food and Drug Administration
5630 Fishers Lane, Rm.
1061
Rockville, MD 20852
Dear Ms. Roth,
+ Read More
article
Milken Institute Announces Key Initiatives at the 2024 Global Conference to Shape the Future of Health
Esther Krofah, executive vice president of Milken Institute Health, (pictured at left) with Emma Wal
msley, CEO of GSK, (right) at the 2024 Milken Institute Global Conference.
+ Read More
article
The 2024-2025 FasterCures LeadersLink Cohort
The 2024–2025 FasterCures’ LeadersLink program cohort has been carefully selected from a highly comp
etitive pool of candidates.
+ Read More
article
TRAIN Newsletter — April 2024
TRAIN eNews is delivered directly to organizations participating in The Research Acceleration and In
novation Network (TRAIN).
+ Read More
article
FasterCures Quarterly Update—April 2024
In This Newsletter
New FasterCures Team Member
Policy Updates
Events and Convenings Recap
FasterCur
es in the Community
+ Read More
video
Building Impactful, Transparent, and Reciprocal Relationships with Industry Partners
How can patient organizations hoping to leverage the resources of industry researchers attract the
ir support and establish formal industry partnerships?
+ Read More